DFTX
DefiniumยทNASDAQ
--
--(--)
--
--(--)
DFTX Profile
Definium Therapeutics, Inc.
A clinical stage neuropharmaceutical development company
One World Trade Center, Suite 8500, New York, New York 10007
--
Definium Therapeutics, Inc., is incorporated in Canada. They are a clinical-stage neurodrug development company that develops psychedelic-based drug candidates through rigorous scientific and clinical trials. Their mission is to discover, develop and deploy psychedelic-inspired drugs and therapies to treat psychiatry, neurology, addiction, pain, and potentially other disorders such as anxiety, substance abuse and withdrawal, and adult attention deficit disorder.
